Literature DB >> 10554097

Oral mucosal permeability and stability of transforming growth factor beta-3 in vitro.

C A Squier1, M J Kremer, A Bruskin, A Rose, J D Haley.   

Abstract

PURPOSE: To investigate the permeability and localization of topically applied 125I-TGF-beta3 in porcine floor-of-mouth mucosa as a function of concentration and exposure.
METHODS: The 125I-TGF-beta3 diluted in three different vehicles was applied to the tissue samples mounted in perfusion cells maintained at 37 degrees C. Flux and Kp values were calculated from the perfusate collected over a 24 hour period. The quantity of 125I-TGF-beta3 present in the tissue was determined by horizontal sectioning and subsequent counting. The stability of 125I-TGF-beta3 in saliva and in the tissue was analyzed by SDS polyacrylamide gradient gel electrophoresis.
RESULTS: 125I-TGF-beta3 was relatively stable in saliva and in the epithelium; approximately 50% of the total counts in the deeper epithelium were resident in the 25kDa TGF-beta3 homodimer. A steady-state flux was reached approximately 6 hours post application and Kp value was 4.0+/-0.6 x 10(-6) (mean +/- sem). Penetration of 125I-TGF-beta3 to the basal cell layer was concentration dependent but reached nanomolar concentrations even after extensive surface rinsing, representing over one-thousand fold the IC50 for epithelial cell cycle arrest.
CONCLUSIONS: The data suggest that topical application of TGF-beta3 to the oral mucosa in an appropriate vehicle can provide effective therapeutic delivery to the tissue.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10554097     DOI: 10.1023/a:1015052520467

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

Review 1.  Drug delivery via the mucous membranes of the oral cavity.

Authors:  D Harris; J R Robinson
Journal:  J Pharm Sci       Date:  1992-01       Impact factor: 3.534

2.  Crystallization and preliminary X-ray analysis of recombinant human transforming growth factor beta 2.

Authors:  M P Schlunegger; N Cerletti; D A Cox; G K McMaster; A Schmitz; M G Grütter
Journal:  FEBS Lett       Date:  1992-05-25       Impact factor: 4.124

3.  Oral complications of cancer therapies. Mucosal alterations.

Authors:  C A Squier
Journal:  NCI Monogr       Date:  1990

4.  Penetration pathways of different compounds through epidermis and oral epithelia.

Authors:  C A Squier; C A Lesch
Journal:  J Oral Pathol       Date:  1988-11

5.  The permeability of human oral mucosa and skin to water.

Authors:  C A Lesch; C A Squier; A Cruchley; D M Williams; P Speight
Journal:  J Dent Res       Date:  1989-09       Impact factor: 6.116

6.  Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis.

Authors:  S T Sonis; A G Van Vugt; J P Brien; A D Muska; A M Bruskin; A Rose; J D Haley
Journal:  Oral Oncol       Date:  1997-01       Impact factor: 5.337

7.  Umbilical cord transforming growth factor-beta 3: isolation, comparison with recombinant TGF-beta 3 and cellular localization.

Authors:  A A Stewart; J D Haley; G Y Qu; K Stam; D Fenyö; B T Chait; D R Marshak; A Y Ng; G Marley; K K Iwata
Journal:  Growth Factors       Date:  1996       Impact factor: 2.511

Review 8.  Transforming growth factor-beta 3.

Authors:  D A Cox
Journal:  Cell Biol Int       Date:  1995-05       Impact factor: 3.612

Review 9.  Cellular and molecular basis of barrier function in oral epithelium.

Authors:  P W Wertz; C A Squier
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1991       Impact factor: 4.889

10.  Pretreatment with transforming growth factor beta-3 protects small intestinal stem cells against radiation damage in vivo.

Authors:  C S Potten; D Booth; J D Haley
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  6 in total

1.  In vitro characterization of chitosan gels for buccal delivery of celecoxib: influence of a penetration enhancer.

Authors:  Yara Peluso Cid; Vinícius Pedrazzi; Valéria Pereira de Sousa; Maria Bernadete Riemma Pierre
Journal:  AAPS PharmSciTech       Date:  2011-12-09       Impact factor: 3.246

2.  Effect of freezing and type of mucosa on ex vivo drug permeability parameters.

Authors:  Thiago Caon; Cláudia Maria Oliveira Simões
Journal:  AAPS PharmSciTech       Date:  2011-05-04       Impact factor: 3.246

3.  Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose.

Authors:  Nitin Nitin; Alicia L Carlson; Tim Muldoon; Adel K El-Naggar; Ann Gillenwater; Rebecca Richards-Kortum
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

4.  Cytolysins augment superantigen penetration of stratified mucosa.

Authors:  Amanda J Brosnahan; Mary J Mantz; Christopher A Squier; Marnie L Peterson; Patrick M Schlievert
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

Review 5.  Biomarker selection and imaging design in cancer: A link with biochemical pathways for imminent engineering.

Authors:  Joham Surfraz Ali; Noor Ul Ain; Sania Naz; Muhammad Zia
Journal:  Heliyon       Date:  2020-02-03

Review 6.  Oral drug delivery for immunoengineering.

Authors:  Tien Le; Brian Aguilar; Joslyn L Mangal; Abhinav P Acharya
Journal:  Bioeng Transl Med       Date:  2021-08-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.